MedDataX Logo

The Impact of Mindfulness-Based Psychoeducation on Perceived Stress, Intolerance of Uncertainty, and Cognitive Flexibility in Patients With Anxiety Disorders: A Randomized Controlled Trial

NCT ID: NCT07299045

Last Updated: 2025-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-01

Study Completion Date

2024-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mindfulness-based interventions, which cultivate the capacity to remain present with difficult thoughts and emotions and to maintain psychological well-being in the face of such challenges, have been shown to facilitate positive change in individuals with anxiety disorders. The present study aimed to investigate the effects of a mindfulness-based psychoeducational program on perceived stress, intolerance of uncertainty, and cognitive flexibility among individuals diagnosed with anxiety disorders.

This randomized controlled trial with pre-test, post-test, and one-month follow-up measurements was conducted with individuals who applied to the Psychiatry Outpatient Clinic at Aydın Atatürk State Hospital and were diagnosed with anxiety disorders. A total of 50 participants were included in the study and were randomly assigned to groups (Experimental: 25; Control: 25). The experimental group underwent an 8-week mindfulness-based psychoeducational program, while no intervention was provided to the control group. Research data were collected using the Personal Information Form, Perceived Stress Scale (PSS), Intolerance of Uncertainty Scale (IUS-12), and Cognitive Flexibility Scale (CFS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Disorders Mindfulness Perceived Stress Intolerance of Uncertainty Cognitive Flexibility

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Anxiety disorders Mindfulness Perceived Stress Intolerance of Uncertainty Cognitive Flexibility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Since the intervention component of the study included tangible elements such as training and counseling, it was not possible to blind participants or researchers to group allocation. The assignment of participants to groups was carried out by the researchers without blinding. Data for the personal information form and all dependent variables of the study were collected through self-report at both the pretest and posttest stages, and in this respect, the researchers were blinded to the scale results.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Participants receive a structured mindfulness-based psychoeducation programin addition to standard care. The intervention includes psychoeducational sessions, mindfulness exercises, and practical strategies.

Group Type EXPERIMENTAL

Mindfulness-Based Psychoeducational Program

Intervention Type OTHER

Mindfulness-Based Psychoeducational Program contains 8-sessions named as "Introduction to mindfulness, Exploring Mindfulness, Becoming Mindful of the Autopilot, Being in the Body, Meeting Stress with Mindfulness, Mindful Communication, Staying with Difficulties, A New Beginning"

Control group

Participants receive standard care only without any additional psychoeducational or mindfulness-based intervention.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mindfulness-Based Psychoeducational Program

Mindfulness-Based Psychoeducational Program contains 8-sessions named as "Introduction to mindfulness, Exploring Mindfulness, Becoming Mindful of the Autopilot, Being in the Body, Meeting Stress with Mindfulness, Mindful Communication, Staying with Difficulties, A New Beginning"

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being literate
* Having a diagnosed anxiety disorder
* Being 18 years of age or older

Exclusion Criteria

* Presence of an acute episode of the illness
* Lack of ability to engage in communication
* currently receiving another form of psychotherapy
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aydin Adnan Menderes University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eda Mert

PhD Graduated

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Eda Mert

Aydin, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023/369

Identifier Type: -

Identifier Source: org_study_id